Total Funding
35
Total FundingPost-IPO Debt raised
Growth Score
pts
Heat Score
-26 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
206382
Irras is a commercial-stage medical technology company.
- Martin Mertens: Sales Director DACH & Western EuropePast Role: Spiegelberg, Director of global sales and marketing
Will Martin: President & Chief Commercial Officer
About the Company
IRRAS AB is a medical technology company that is developing breakthrough devices to meet the challenges of fluid control and management for a broad range of brain pathologies, CNS therapeutic applications and procedures. IRRAS has successfully developed first-in-class instruments and catheters for the clinical, monitoring and surgical applications
for brain pathology indications called IRRAflow™. Our transformative technology provides intelligent, dynamic control of brain fluids, for irrigation and aspiration, precise infusion of fluids and intracranial pressure monitoring all in one unit, without additional equipment or more invasive procedures.
